The rationale for incorporating nonpharmacologic therapy in the treatment of borderline - Mild hypertension

Abstract:

The use of pharmacologic agents to lower blood pressure in borderline-mild hypertension has not been conclusively shown to improve morbidity and mortality outcomes. Since the risks and side-effects of drug treatment in borderline-mild hypertension may outweigh the benefits, nonpharmacologic therapy is suggested as an important first step in the treatment of most patients with blood pressure levels between 140/90 mm Hg and 160/100 mm Hg, and also individuals at risk for developing hypertension. The possible roles of lifestyle related excesses including dietary sodium, saturated fat, alcohol, body fat, and psychological stress; and deficiences of dietary potassium, calcium, and physical activity as contributors to elevated blood pressure are explored, with implications for nonpharmacologic therapy.

Año de publicación:

1984

Keywords:

Fuente:

scopus